Current Research and Future Trends Expanding Clinical Applications Ongoing studies are exploring the role of AOD-9604 in treating metabolic conditions such as: Type 2 diabetes Insulin resistance Non-alcoholic fatty liver disease (NAFLD) Up to 95% of individuals with type 2 diabetes also present with NAFLD, emphasizing the need for multi-functional metabolic therapies Joint Health & Cartilage Regeneration In addition to fat metabolism, AOD-9604 may stimulate cartilage repair and support joint health
: 5-Amino-1MQ , ,
As reported by von Mentzer, et al
Allergy Patients with a history of allergy to cyanocobalamin, pyridoxine, thiamine, riboflavine, nicotinamide, D-panthenol, or any component of Optineuron Injection should not use this injection
If prescribed a DOAC (rivaroxaban, apixaban), take exactly as directed some require twice-daily dosing initially
Although the peptide is often labeled as a gut peptide, and some even claim that it shares a similar structure to gastroprotective peptides found in the human digestive system, the BPC-157 sequence is not known to occur in nature
